Zenas BioPharma, Inc. Amortization of Debt Discount (Premium)
Zenas BioPharma, Inc. (ZBIO) reported Amortization of Debt Discount (Premium) of -$1.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-13
- Zenas BioPharma, Inc. amortization of debt discount (premium) for the quarter ending 2026-06-30 was -$1.29M.
- Zenas BioPharma, Inc. amortization of debt discount (premium) for the quarter ending 2026-03-31 was -$110.00K.
- Zenas BioPharma, Inc. amortization of debt discount (premium) for the quarter ending 2025-12-31 was -$421.00K.
- Zenas BioPharma, Inc. amortization of debt discount (premium) for the quarter ending 2025-09-30 was -$193.00K.
- Zenas BioPharma, Inc. amortization of debt discount (premium) for fiscal 2025 was -$1.93M.
- Zenas BioPharma, Inc. amortization of debt discount (premium) for fiscal 2024 was -$602.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.40M 10-Q · filed 2026-08-13 | -$1.82M derived: sum of 3 quarters · filed 2026-08-13 | -$2.01M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$110.00K 10-Q · filed 2026-05-13 | -$531.00K derived: sum of 2 quarters · filed 2026-05-13 | -$724.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.66M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$614.00K derived: sum of 2 quarters · filed 2026-03-16 | -$1.55M derived: sum of 3 quarters · filed 2026-08-13 | -$1.93M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.13M derived: sum of 2 quarters · filed 2026-08-13 | -$1.51M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$935.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.32M 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$382.00K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$602.00K 10-K · filed 2026-03-16 |